I have had this same problem. I started drawing the mechanism of action of the two non selective alpha blockers: Phenoxybenzamine and Phentolamine. My problem is that if pheochromocytoma has an already increase cathecolamine production in excess which causes enhancement of vasoconstriction by alpha 1 and beta 1 ( hypertension and increased heart rate) why give a non selective alpha antagonist/blocker if it also inhibits alpha 2 which functions as modulatory/regulatory enzyme which blocks the release of noepinephrine in the synaptic cleft. If you give an alpha blocker you will also increase more cathecolamine release and inhibit reuptake of norepinephrine by NET. This will enhance beta-1 adrenegernic receptor action in heart ( increase heart rate will lead to tachycardia and eventually atrial fibrillation), also it will increase water and salt retention in kidney reabsoprtion ( increase renin release) which it will negate hypotensive effect of alpha 1 blockade. While some of you put out a half answer saying that phenoxybenzamine is a non competitive irreversible drug that it will take 24-48 hrs to for new added receptors to work, it will only exert effect on hypertension, but it will exacerbate tachycardia, this could be deadly. This is why you administer beta blockers after alpha blockade, to control heart rate. In 2017 a new england journal article mention that use non selective alpha blockade has been eliminated in some countries because of the tachycardia exarcebation, and alpha-1 blockers have been the prefer method of treatment, specially doxazosin. The problem with the treatment with alpha-1 blockers is that all are reversible competitive drugs, meaning that if the concetration of cathecolamines is bigger than the effect of the drug it will still increase the hypertension and increasing the dosage will lead to more side effects. And alpha-1 blockers and alpha-2 agonist are never first line treatment for severe hypertension, they are only use concomitant with other antihypertensives because the decrease is progressive not inmmediately and your trying to prevent end-organ damage, ACV, infarct. I hope it clarifies some things even if it does not answer properly the problem.